CliffBio
small molecule

SODIUM CHLORIDE 14.6%

SODIUM CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameSODIUM CHLORIDE 14.6%
Active ingredientSODIUM CHLORIDE
Strength50MEQ/20ML (2.5MEQ/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalApril 2021
Marketing statusRX

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.